Charles River raises FY23 EPS view to $10.30-$10.90 from $9.90-$10.90

Consensus $10.37. Raises FY23 revenue view to up 2.5%-4.5% from 2%-4.5%, consensus $4.13B. The company said, “The Company is updating its 2023 financial guidance, which was previously provided on May 11, 2023. The Company is narrowing its revenue growth and non-GAAP earnings per share outlooks to largely reflect its solid first-half financial performance and the successful implementation of mitigation efforts around NHP supply constraints. These benefits are anticipated to be partially offset by near-term demand trends as biopharmaceutical clients appear to be reprioritizing their pipelines and tightening R&D budgets.”